MVIS US Listed Pharmaceutical 25 Index

The modified market cap-weighted index tracks the performance of the largest and most liquid US-listed companies that derive at least 50% of their revenues from pharmaceuticals. The pure-play index contains only companies which are engaged primarily engaged in research (incl. research contractors) and development as well as production, marketing and sales of pharmaceuticals. Pharmacies are excluded. The MVIS US Listed Pharmaceutical 25 Index (MVPPH) has been licensed to underlie financial products with currently USD 157.99 million in assets under management.

Index Parameters

Market Capitalisation values are updated daily.

Launch Date: 12 Aug 2011
Calculator: Solactive AG
Dissemination: Realtime
Dissemination Period: 09:30 - 16:30 (EST)
Type: Sector
Currency: USD
Components: 25
Base Date: 29 Sep 2000
Base Value: 1000
Full Market Cap: 1,901.56 bn USD
Free-Float Market Cap: 1,568.89 bn USD
Next Review: 20 Sep 2019

Identifiers

PriceTotal Return NetTotal Return Gross
ISIN:DE000SLA0LS2DE000SLA0LT0DE000SLA1CM2
Sedol:B4RGLR2B4LWXJ2B88HTJ0
WKN:SLA0LSSLA0LTSLA1CM
Bloomberg:MVPPHMVPPHTRMVPPHTRG
Reuters:.MVPPH.MVPPHTR.MVPPHTRG
Telekurs:CH13624427CH13624431CH20729426
FIGI:BBG001YHPLG1BBG001YHPLH0BBG00440CW84

Non-Dissemination Days

Following the index methodology as described in the MVIS Global Equity Index Guide, the Index will not be disseminated on the following days:

  • 01 Jan 2019
  • 21 Jan 2019
  • 18 Feb 2019
  • 19 Apr 2019
  • 27 May 2019
  • 04 Jul 2019
  • 02 Sep 2019
  • 28 Nov 2019
  • 25 Dec 2019
Up